German pharmaceutical behemoth Bayer has hiked its offer price to buy Monsanto to 65 billion USD which includes Monsanto’s debts as well. Bayer has been in negotiation with Monsanto since May, 2016 and its initial offer of 64 billion USD was rejected by Monsanto shareholders. The current offer increases per share value of Monsanto to 127.50 USD per share. According to reports, Bayer is ready to pay 130 USD per share to close the deal.
If the takeover is successful, Bayer will own the largest GMO (genetically modified organism) producer of the world and will increase its global footprint to deeper levels. Monsanto is comparing several other offers. They released statement in Wall Street Journal saying, “Monsanto is continuing these conversations as it evaluates this proposal, as well as proposals from other parties and other strategic alternatives to enable its Board of Directors to determine if a transaction in the best interests of its shareowners can be realized.” Monsanto is likely to accept any of these offers in the near future.